Cargando…
Can the Open Label Placebo Rationale Be Optimized?
Autores principales: | Heiss, Uwe, Rosenfield, Maayan, Bernstein, Michael H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915569/ https://www.ncbi.nlm.nih.gov/pubmed/35295434 http://dx.doi.org/10.3389/fpain.2021.734882 |
Ejemplares similares
-
The Use of Conditioning Open-Label Placebo in Opioid Dose Reduction: A Case Report and Literature Review
por: Estudillo-Guerra, Maria A., et al.
Publicado: (2021) -
Editorial: Placebo Effect in Pain and Pain Treatment
por: Bernstein, Michael H., et al.
Publicado: (2022) -
Part of pain labelled neuropathic in rheumatic disease might be rather nociplastic
por: Bailly, Florian, et al.
Publicado: (2020) -
Placebo, nocebo: Believing in the field of medicine
por: Meissner, Karin
Publicado: (2022) -
Injection Botulinum Toxin A in Treatment of Resistant Chronic Low Back Pain: A Prospective Open-Label Study
por: Sahoo, Jagannatha, et al.
Publicado: (2021)